Navigation Links
Erg gene key to blood stem cell 'self-renewal'
Date:2/16/2011

Scientists from the Walter and Eliza Hall Institute have begun to unravel how blood stem cells regenerate themselves, identifying a key gene required for the process.

The discovery that the Erg gene is vitally important to blood stem cells' unique ability to self-renew could give scientists new opportunities to use blood stem cells for tissue repair, transplantation and other therapeutic applications.

Professor Doug Hilton, Dr Samir Taoudi and colleagues from the institute's Molecular Medicine and Cancer and Haematology divisions led the study. Dr Taoudi said the research aimed to understand how blood stem cells are made.

"One of the key features of blood stem cells, one that could be exploited for therapeutic use, is their ability to regenerate or renew themselves," Dr Taoudi said. "However, relatively little is known about how this occurs, or the molecular pathways that specifically control regeneration."

Blood stem cells are required to produce and maintain the blood system throughout an organism's lifetime. They are multipotent cells, meaning they are able to form any cell of the blood system (but not other cells), and they self-renew, so they are a source of endless supply. However, one major barrier to their therapeutic use is that the cells can only be isolated in numbers too low for practical use and efforts to expand the number of cells often causes them to turn into more mature cells.

"At the moment, if you take stem cells from a person and try to expand them, many of the stem cells lose their ability to regenerate," Dr Taoudi said. "The practical aim of our research is to find ways in which you could take stem cells collected from bone marrow or cord blood and 'switch on' expression of particular sets of genes, encouraging the stem cells to expand, essentially creating your own endless supply of blood stem cells."

Institute researchers had previously discovered that ERG was vital for the proper function of adult blood stem cells. They decided to look at blood stem cells in a developing embryo, a time when the cells are particularly active, to determine ERG's role in stem cell production and maintenance.

"We found that during development, ERG was not needed for the original blood stem cells to be made, or to produce mature blood cells," Dr Taoudi said. "But without ERG, these new blood stem cells rapidly decreased as they divided to produce more blood, so that they were almost completely exhausted by the time the mouse was born."

Further testing revealed that two other genes important in embryonic development, GATA2 and RUNX1, were controlled by ERG at the blood producing stage of development.

"These genes are called transcription factors, they are the 'switches' that turn on and off other genes," Dr Taoudi said. "Individually, these genes are not essential for regeneration, but if you lose both, the stem cells are quickly exhausted. This is a key part of the puzzle, but we will continue to work to find out how these genes directly control self-renewal, and the signals that actually tell the stem cell to regenerate."

Dr Taoudi said that although the finding had promise for the future therapeutic use of blood stem cells, there was still a lot of work to be done.

"We have found part of the pathway required for the expansion of blood stem cells under normal conditions, but from a translation perspective, we still need to establish whether increasing expression of these genes will actually lead to expansion in a culture dish," he said.


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related biology news :

1. Blood-clotting protein linked to cancer and septicemia
2. Conversion of brain tumor cells into blood vessels thwarts treatment efforts
3. Red blood cell hormone modulates the immune system
4. Common antibiotics and blood pressure medication may result in hospitalization
5. Blood pressure control system found in kidneys structural units
6. New method will triple amount of genetic information from newborn blood spot screenings
7. Biomedical breakthrough: Blood vessels for lab-grown tissues
8. Researchers investigate why a limited number of white blood cells are attracted to injured tissue
9. UTHealth studies cord blood stem cells for pediatric traumatic brain injury
10. High red blood cell folate levels linked to silenced tumor-suppressors
11. Cord blood cell transplantation provides improvement for severely brain-injured child
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Erg gene key to blood stem cell 'self-renewal'
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... 21, 2017 , ... The Conference Forum has announced the launch of the ... May 10-11, 2017, at the Colonnade Hotel in Boston, MA. The CMO Summit is ... learning, benchmarking and support. , “The Chief Medical Officer faces a unique set of ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Society for Immunotherapy ... as outlined in the Administration’s recently published fiscal year 2018 budget request. , ... of Health (NIH) by $5.8 billion or roughly 20% of its total budget. If ...
(Date:3/22/2017)... , March 22, 2017  Personal Genome ... its cancer testing contract with the U.S. Department ... tumor profiling assay with the company,s new CancerSELECT ... comprehensive, clinically actionable pan-cancer profiling test that includes ... assess potential patient response to checkpoint inhibitor immunotherapies. ...
(Date:3/20/2017)... ... March 20, 2017 , ... SSCI and Whitehouse Laboratories, divisions of Albany ... ! Sponsored by the Parenteral Drug Association (PDA), the New York Interphex Show ... professionals in attendance and more than 625 exhibitors, the educational and networking opportunities are ...
Breaking Biology Technology: